- Transformational acquisition, expanding geography and
accelerating growth
- Expands Sagicor's offering of protection and wealth
management solutions into Canada
- Positions Sagicor as a leading provider of protection and
savings products to the middle-market in North America
- ivari is the second largest provider of universal life
insurance in Canada(1)
- ivari adds C$13.9 billion to
Sagicor's existing assets; pro-forma debt securities to move from
69% to 83%(2) investment grade as of year end
2021
- Immediately accretive to EPS and BVPS by double digit
percentage points(3)(4)
- Improvement to MCCSR ratio(3); debt to
capital ratio(3) approximately
unchanged(4)
TORONTO and BARBADOS,
Aug. 25,
2022 /CNW/ - Sagicor Financial Company Ltd.
("Sagicor" or the "Company") (TSX: SFC), a leading financial
services provider in the Caribbean
with a growing presence in the U.S., has entered into a definitive
agreement to acquire ivari, a subsidiary of Wilton Re Ltd., subject
to the satisfaction of customary conditions, including required
regulatory approvals.
The expected consideration, to be paid in cash at closing, is
C$325 million, subject to certain
adjustments. This purchase price assumes funding at ivari's current
target total capital ratio under the LICAT 2023 capital adequacy
standard recently finalized by OSFI and following the
implementation of IFRS 17, both of which will be in force
commencing January 1, 2023. Prior to
the closing, ivari is expected to have additional equity capital
injected into the business to meet this new standard, which is
reflected in the above expected purchase price.
Headquartered in Toronto, ivari
is a leading middle-market individual life insurer in Canada with over 80 years of history in the
region. ivari provides individual life and critical illness
insurance solutions for the Canadian middle-market. Currently,
ivari has approximately 700,000 policyholders across Canada and has over 250 employees.
The acquisition of ivari aligns with Sagicor's business strategy
of growing in individual life insurance and diversifying into
adjacent geographic markets. Canada has a large, well-established, and
growing life insurance market. ivari has historically proven its
ability to grow, particularly in universal life insurance with an
11% new paid premium compound annual growth rate from 2017 to
2021(5). This acquisition would result in a Caribbean-headquartered international life
insurance company with major operations in the Caribbean, the U.S., and Canada. On a pro forma basis, Sagicor would
have over US$20 billion of combined
total assets and approximately US$2.6
billion of annual total gross premium revenue as of year end
2021. The transaction combines Sagicor's over 180 years of
experience in individual life insurance and brings on ivari's high
caliber team, efficient operating platform, strong advisory
channels and focused business model that is scalable for
growth.
Dodridge
Miller, Group President and Chief Executive Officer of
Sagicor, said:
"Today we have taken a new step in shaping Sagicor's future. The
acquisition of ivari transforms Sagicor into a leading North
American insurer serving the middle-market in addition to our
market leadership in the Caribbean. We are excited about ivari's
leading position in the Canadian market and its focus on improving
its customers' financial well-being. It is a scaled business primed
for growth with C$13.9 billion in
well-managed assets as of year end 2021 and a dedicated and focused
management team. Through this acquisition, Sagicor will double the
size of its balance sheet and deliver its over 180 years of
experience in individual life insurance to the Canadian
market."
Todd
Lawrence, President and Chief Executive Officer of ivari,
said:
"ivari is pleased to join the Sagicor Group of companies. Over
the past several years, we have simplified our business model to
focus on where we have scale and deep and meaningful relationships
to provide exceptional service to our advisors and customers. ivari
is focused on accelerating our growth in the underserved
middle-market in Canada and
distributes through a strong independent distribution network based
on a long history of relationships built on trust. ivari's
customers, distribution network and other stakeholders will
continue to experience the same level of service they are
accustomed to. The team's dedication to providing excellent service
continues. We are excited by our strong growth prospects and what
the future of ivari holds as part of the Sagicor Group of
companies."
The acquisition is expected to be immediately accretive. Based
on ivari's 2021 net income of C$74
million, and assuming the financing as contemplated, the
transaction would be greater than 25% accretive on an earnings per
share pro forma 2021 basis(6). Furthermore, the
transaction internal rate of return is well in excess of Sagicor's
targets. Sagicor intends to continue to maintain a strong
capital(7) position post-acquisition. Sagicor's
pro-forma MCCSR(7) ratio is expected to improve by over
10 percentage points and its debt to capital
ratio(8) is expected to remain approximately
unchanged. Under IFRS 17, management expects a similarly attractive
financial impact.(9)
The transaction is expected to be financed largely through new
debt and cash on hand. A commitment for up to US$320 million of new debt financing has been
entered into in the form of a 5-year senior secured term loan
facility. As part of its capital management strategy, Sagicor may
opt to replace or refinance this term loan with debentures issued
in the debt capital markets or other financing sources in whole or
in part if and when appropriate.
The share purchase agreement and new debt commitment, and an
investor presentation, will be filed on SEDAR in the near
future.
The transaction is expected to close in the next 6 to 12 months
and is subject to receipt of regulatory approvals and satisfaction
of customary closing conditions.
Conference Call
Sagicor Financial Company Ltd. will host a conference call for
analysts and investors to discuss the acquisition on August 25, 2022, at 5:00
p.m. Eastern Daylight Time in Toronto (5:00
p.m. Atlantic Standard Time in Barbados and Trinidad and Tobago, 4:00 p.m. Eastern Standard Time in Jamaica). To listen to the call via live audio
webcast, visit the Company's website at www.sagicor.com, under the
tab "Investor Relations." The conference call is also available by
dialing 1-416-764-8688 or 1-888-390-0546 (North American toll free)
or 08006522435 (United Kingdom) or
1-866-290-2216 (Barbados) or
1-800-207-8221 (Trinidad),
passcode 44731384. A replay will also be available until
September 25, 2022, by dialing
1-416-764-8677 or 1-888-390-0541 (North American toll free),
passcode 731384#. A transcript of the call will also be made
available on www.sagicor.com.
Advisors
National Bank Financial acted as lead financial advisor, J.P.
Morgan and RBC Capital Markets acted as financial advisors, and
Stikeman Elliott LLP and Paul Hastings LLP acted as legal advisors
to Sagicor.
About Sagicor Financial Company
Ltd.
Sagicor Financial Company Ltd. (TSX: SFC) is a leading financial
services provider in the Caribbean, with over 180 years of history, and
has a growing presence as a provider of life insurance products in
the United States. Sagicor offers
a wide range of products and services, including life, health, and
general insurance, banking, pensions, annuities, and real estate.
Sagicor's registered office is located at Clarendon House, 2 Church
Street, Hamilton, HM 11,
Bermuda, with its principal office
located at Cecil F De Caires Building, Wildey, St. Michael, Barbados. Additional
information about Sagicor can be obtained by visiting
www.sagicor.com.
About ivari
With a national network of thousands of independent,
professional advisors, ivari provides a full range of life
insurance products to help Canadians make the right choice for
their protection needs. ivari had C$13.9
billion in total assets and total gross premium revenue of
C$968 million as at and for the year
ended 2021. ivari's head office is located at 200-5000 Yonge
Street, Toronto, Ontario, M2N 7J8,
Canada. Additional information about ivari can be obtained by
visiting www.ivari.ca.
Non-IFRS Measures
The Company reports certain non-IFRS measures that are used
to evaluate the performance of its businesses and the performance
of their respective segments. As non-IFRS measures generally do not
have a standardized meaning, they may not be comparable to similar
measures presented by other issuers. Securities regulators require
such measures to be clearly defined and reconciled with their most
comparable IFRS measure.
The Company references non-IFRS measures and insurance
industry metrics in this press release and elsewhere. Non-IFRS
measures are not recognized measures under IFRS and do not have a
standardized meaning prescribed by IFRS and are therefore unlikely
to be comparable to similar measures presented by other companies.
Rather, these are provided as additional information to complement
those IFRS measures by providing further understanding of the
results of the operations of the Company from management's
perspective. Accordingly, these measures should not be considered
in isolation, nor as a substitute for analysis of the Company's
financial information reported under IFRS. Non-IFRS measures used
to analyze the performance of the Company's businesses include but
are not limited to: return on shareholders' equity, book value per
share, debt to capital ratio, total capital and Minimum Continuing
Capital and Surplus Requirements. Please see the "Non-IFRS
Financial Information" section of Sagicor's Q2 2022 MD&A as
filed on SEDAR, which is incorporated by reference herein, and the
discussion below for information regarding these non-IFRS
measures.
Return on Shareholders' Equity (ROE): IFRS does
not prescribe the calculation of return on shareholders' equity and
therefore a comparable measure under IFRS is not available. To
determine this measure, reported net income/(loss) attributable to
shareholders is divided by the total weighted average common
shareholders' equity for the period. The quarterly return on
shareholders' equity is annualised. The ROE provides an indication
of the overall profitability of the Company.
Book value and book value per share (BVPS): To
determine the book value per share, shareholders' equity is divided
by the number of shares outstanding at the period end, net of any
treasury shares. Book value is shareholders' equity. All
components of this measure are IFRS measures.
Debt to capital ratio: The debt to capital
ratio is the ratio of notes and loans payable (refer to note 16 to
the 2021 audited consolidated financial statements) to total
capital (excluding participating accounts), where capital is
defined as the sum of notes and loans payable and total equity
excluding participating accounts. This ratio measures the
proportion of debt the Company uses to finance its operations as
compared with its capital.
Total capital: This measure provides an
indicator for evaluating the Company's performance. Total capital
is the sum of shareholders' equity, notes and loans payable and
non-controlling interest. This measure is the sum of several IFRS
measures.
Minimum Continuing Capital and Surplus Requirements
(MCCSR): The MCCSR is a capital adequacy measure for
life insurance companies that was previously utilized by the Office
of the Superintendent of Financial Institutions of Canada. It
was used to monitor insurers maintaining adequate capital to meet
their financial obligations, with 150% being the minimum standard
that was recommended by the Canadian regulator when it was in
effect; insurance companies were expected to establish and meet an
internal target greater than 150%. Refer to note 45.2 to the
Company's 2021 audited financial statements, for details.
IFRS does not prescribe the calculation for the MCCSR, therefore
a comparable measure under IFRS is not available.
Forward-Looking Information /
Cautionary Statements
Certain information contained in this news release may be
forward-looking statements within the meaning of Canadian
securities laws. Forward-looking statements are often, but not
always identified by the use of words such as "expect",
"anticipate", "believe", "foresee", "could", "estimate", "goal",
"intend", "plan", "seek", "will", "may", "would" and "should" and
similar expressions or words suggesting future outcomes. These
forward-looking statements reflect material factors and
expectations and assumptions of Sagicor. These forward-looking
statements include the assumptions: that the transaction is
able to be completed on the timelines and on the terms currently
anticipated; that all regulatory approvals can be obtained on the
timelines and in the manner currently anticipated; that the
anticipated benefits of the transaction are able to be achieved;
that the businesses of both Sagicor and ivari will continue to
operate in a manner consistent with past practice; that the
parties' transition plans are effective; that ivari is able
to maintain the same target regulatory capital ratio range
post-closing as applies under its current ownership (failing which
additional regulatory capital infusions could be required to be
made by Sagicor); that no material and mutually agreed management
actions out of the ordinary course of business occur at ivari
(if they do, then the net benefit to ivari would be shared between
Sagicor and the seller and the purchase price would increase
accordingly, and the required regulatory capital infusion and/or
the purchase price would be less); and that no additional changes
to OSFI's proposed LICAT 2023 regulatory capital regime and/or to
IFRS 17 occur before their January 1,
2023 implementation dates Sagicor's estimates, beliefs
and assumptions are inherently subject to uncertainties and
contingencies regarding future events and, as such, are subject to
change. Risks and uncertainties not presently known to Sagicor or
that it presently believes are not material could cause actual
results or events to differ materially from those expressed in its
forward-looking statements. Additional information on these and
other factors that could affect events and results are included in
other documents and reports that will be filed by Sagicor with
applicable securities regulatory authorities and may be accessed
through the SEDAR website (www.sedar.com). Readers are cautioned
not to place undue reliance on these forward-looking statements,
which reflect Sagicor's expectations only as of the date of this
press release. Sagicor disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by law.
|
__________________________
|
(1)
|
Source: LIMRA's
Canadian Individual Life Insurance Sales 2021. LIMRA numbers are
carrier-reported, and participants vary year-to- year, impacting
reported market share.
|
(2)
|
Accounting for planned
sale of approximately C$700 million of direct equities and
reinvestment into investment grade bonds by ivari by year end
2022.
|
(3)
|
Represents a non-IFRS
measure. See the "Non-IFRS Measures" section in this press release
for relevant information about such measures.
|
(4)
|
See the
"Forward-Looking Information / Cautionary Statements" section in
this press release.
|
(5)
|
Based on ivari company
reports.
|
(6)
|
See the
"Forward-Looking Information / Cautionary Statements" section in
this press release.
|
(7)
|
Represents a non-IFRS
measure. See the "Non-IFRS Measures" section in this press release
for relevant information about such measures.
|
(8)
|
Represents a non-IFRS
measure. See the "Non-IFRS Measures" section in this press release
for relevant information about such measures.
|
(9)
|
See the
"Forward-Looking Information / Cautionary Statements" section in
this press release.
|
SOURCE Sagicor Financial Company Ltd.